Cytonus Therapeutics

[Not Yet Scheduled]
Cytonus Therapeutics is a cell-based platform technology focused on immune-oncology and gene therapies for devastative and rare diseases. This is achievable through Cytonus’ proprietary technology of a unique cell-line: the Cargocyte™.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
CA-IL-12
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
President and CEO
Cytonus Therapeutics Inc.